A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
from Health https://ift.tt/2pKSyfo
October 09, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
Antibody Drug to Protect the Vulnerable From Covid Goes UnusedThe treatment could be lifesaving for many who cannot get protection from the vaccine, but confusion about the drug has made some doctors slow to prescribe it. from NYT > Health https://ift.tt/jtAyXOb … Read More
A funding dispute with G.O.P. senators may complicate Biden’s efforts on antivirals and tests. from NYT > Health https://ift.tt/3gtae5j … Read More
The Synthetic Nicotine Loophole Fueling a Return to Teenage VapingSales are rising of flavored e-cigarettes using synthetic nicotine that evades regulatory oversight, a gap that lawmakers are now trying to close. from NYT > Health https://ift.tt/KhSP3Qa … Read More
Most Women Denied Abortions by Texas Law Got Them Another WayNew data suggests overall abortions declined much less than previously known, because women traveled out of state or ordered pills online. from NYT > Health https://ift.tt/2DkFrbz … Read More
A Nigerian Doctor’s Fight for Equitable Access to VaccinesFor Dr. Ayoade Alakija, saying no was not an option when she was asked to lead efforts to expand Covid-19 testing and treatments to underserved regions. from NYT > Health https://ift.tt/mQrLwdt … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment